Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 728,483 |
|
|||||
| News | - | ||||||
| Day High | 18.81 | Low High |
|||||
| Day Low | 17.29 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc | EYPT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.44 | 2.50% | 18.04 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.72 | 17.29 | 18.81 | 18.04 | 17.60 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,278 | 728,483 | US$ 18.02 | US$ 13,124,262 | - | 5.67 - 30.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:24:19 | 20 | US$ 18.06 | USD |
EyePoint Pharmaceuticals (EYPT) Options Flow Summary
EyePoint Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 898.95M | 49.83M | - | 46.02M | -70.8M | -1.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EyePoint Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYPT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.57 | 18.81 | 15.51 | 16.90 | 982,212 | 0.47 | 2.68% |
| 1 Month | 20.10 | 23.645 | 15.51 | 18.52 | 937,816 | -2.06 | -10.25% |
| 3 Months | 28.91 | 30.99 | 15.51 | 23.06 | 973,171 | -10.87 | -37.60% |
| 6 Months | 6.62 | 30.99 | 5.855 | 20.33 | 1,276,022 | 11.42 | 172.51% |
| 1 Year | 6.29 | 30.99 | 5.67 | 17.08 | 897,151 | 11.75 | 186.80% |
| 3 Years | 10.73 | 30.99 | 2.19 | 14.10 | 515,953 | 7.31 | 68.13% |
| 5 Years | 1.75 | 30.99 | 0.3511 | 7.61 | 640,855 | 16.29 | 930.86% |
EyePoint Pharmaceuticals Description
| EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. |
